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Dynamic BAF chromatin remodeling complex subunit inclusion
promotes temporally distinct gene expression programs
in cardiogenesis
Swetansu K. Hota1,2, Jeffrey R. Johnson1,3, Erik Verschueren1,3, Reuben Thomas1, Aaron M. Blotnick1,2,
Yiwen Zhu4,5, Xin Sun6, Len A. Pennacchio4,5, Nevan J. Krogan1,3 and Benoit G. Bruneau1,2,7,8,*
ABSTRACT
Chromatin remodeling complexes instruct cellular differentiation
and lineage specific transcription. The BRG1/BRM-associated
factor (BAF) complexes are important for several aspects of
differentiation. We show that the catalytic subunit gene Brg1 has a
specific role in cardiac precursors (CPs) to initiate cardiac gene
expression programs and repress non-cardiac expression. Using
immunopurification with mass spectrometry, we have determined the
dynamic composition of BAF complexes during mammalian cardiac
differentiation, identifying several cell-type specific subunits. We
focused on the CP- and cardiomyocyte (CM)-enriched subunits
BAF60c (SMARCD3) and BAF170 (SMARCC2). Baf60c and Baf170
co-regulate gene expression with Brg1 in CPs, and in CMs their loss
results in broadly deregulated cardiac gene expression. BRG1,
BAF60c and BAF170 modulate chromatin accessibility, to promote
accessibility at activated genes while closing chromatin at repressed
genes. BAF60c and BAF170 are required for proper BAF complex
composition, and BAF170 loss leads to retention of BRG1 at
CP-specific sites. Thus, dynamic interdependent BAF complex
subunit assembly modulates chromatin states and thereby participates
in directing temporal gene expression programs in cardiogenesis.
KEY WORDS: Heart, Differentiation, Chromatin, Gene regulation
INRODUCTION
Cell differentiation and organogenesis are regulated by the precise
transcriptional output of a coordinated gene regulatory network
(Davidson, 2010). Duringmammalian development, gene expression
programs are spatially and temporally controlled, with specific sets
of genes being expressed while others are poised or repressed in
a developmental stage-dependent manner. It is considered that
differentiation proceeds as a gradually increasing specification of cell
fates (Moris et al., 2016). Delineating the factors that control crucial
developmental decision points is essential to understand the control
of gene regulation during differentiation and development.
Transcription factor (TF) activity regulates transcriptional output,
and is intimately influenced by the underlying chromatin.
Chromatin remodeling complexes are multi-subunit protein
complexes that alter histone-DNA contact in nucleosomes to
reorganize chromatin and regulate transcription (Bartholomew,
2014; Clapier and Cairns, 2009; Zhou et al., 2016). The BRG1/
BRM-associated factor (BAF) chromatin remodeling complexes are
composed of the mutually exclusive brahma (BRM) or brahma-
related gene 1 (BRG1; also known as SMARCA4) ATPAses, along
with several other structural subunits and their isoforms. These form
diverse BAF complexes that serve specific functions in widely
different cell types and developmental processes (Ho and Crabtree,
2010; Hota and Bruneau, 2016; Wang et al., 1996). BAF complexes
have a specific composition in certain cell types, e.g. an embryonic
stem cell complex that regulates pluripotency (Ho et al., 2011,
2009b) or a neural precursor and neural BAF complexes that
fine-tune neurogenesis (Lessard et al., 2007; Staahl et al., 2013).
Current evidence indicates that a shift in isoforms of non-essential
BAF complex subunits is important for the stepwise transition
from a precursor to a differentiated state in neural and muscle
differentiation (Goljanek-Whysall et al., 2014; Lessard et al., 2007;
Saccone et al., 2014; Staahl et al., 2013; Wu et al., 2007). Mutations
in genes encoding BAF complex subunits have been associated with
various cancers (Pierre and Kadoch, 2017), and some have also
been found in cases of congenital heart disease (CHDs) (Jin et al.,
2017). In the developing heart, subunits of the BAF complex
are involved in diverse aspects of cardiac development (Chang
and Bruneau, 2012; Sun et al., 2018). Brg1 (Smarca4) is
haploinsufficient in the mouse heart, and genetically interacts
with genes encoding DNA-binding transcription factors associated
with CHDs, indicating a potentially general role for BAF complexes
in these common birth defects (Takeuchi et al., 2011).
Differentiation is thought to proceed during development as a
continuous but highly regulated series of milestones, which include
lineage decisions and linear progression towards a terminally
differentiated state. These sequential events can be modeled
effectively using pluripotent stem cells that are subjected to well-
defined differentiation protocols (Loh et al., 2016; Murry and
Keller, 2008). Cardiac differentiation is composed of a stereotyped
set of steps, with the initial formation of cardiogenic mesoderm,
subsequent specialization into multipotent cardiac precursors (CPs)
and then differentiation into beating cardiomyocytes (CMs) (Devine
et al., 2014; Evans et al., 2010; Kattman et al., 2011; Wamstad et al.,
2012). The in vivo embryonic steps are well recapitulated in in vitroReceived 22 November 2018; Accepted 19 February 2019
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differentiation protocols (Kattman et al., 2011; Wamstad et al.,
2012). It is not known which BAF complex subunits are essential
for controlling temporal steps in cardiac differentiation.
Here, we define dynamic BAF complex composition during
mouse CM differentiation. We identify several BAF complex
subunits as enriched in CPs and CMs, and along with BRG1 chose
to focus on BAF60c (also known as SMARCD3) and BAF170 (also
known as SMARCC2). BAF60c is expressed preferentially in the
developing heart, and is important for its morphogenesis (Lickert
et al., 2004; Sun et al., 2018). BAF60c and BAF170 together are the
first subunits to assemble during BAF complex formation
(Mashtalir et al., 2018) and thus may have shared functions. We
find that BRG1 initiates cardiac gene expression programs in
precursor cells, a role shared by BAF60c and BAF170, which also
maintain the cardiac program to facilitate CM differentiation.
BAF60c and BAF170 also regulate BAF complex composition, and
their loss alters chromatin accessibility. Furthermore, we find that
BAF170 facilitates dissociation of BRG1 complexes from their
binding sites upon CM differentiation. These results reveal the
instructive nature that a specific combination of BAF subunits
attains to dictate functional outcomes during lineage commitment
and differentiation.
RESULTS
Brg1 initiates cardiac gene expression programs during
CM differentiation
To model early heart development, we differentiated mouse
embryonic stem cells (mESCs) to cardiac troponin T-positive
(cTnT+) beating cardiac myocytes (Kattman et al., 2011; Wamstad
et al., 2012). To understand the role of the BAF complex ATPase
BRG1 during CM differentiation, we conditionally deleted Brg1
using an inducible Cre-loxP system (Alexander et al., 2015; Ho
et al., 2009b). Addition of 4-hydroxy tamoxifen effectively deleted
exon 17 and 18 of the Brg1 gene encoding part of ATPase domain
(Fig. 1A), leading to a greater than 90% reduction in BRG1 protein
within 36 h (Alexander et al., 2015). Loss of Brg1 at the CP stage,
but not in CMs, inhibited CM differentiation (Fig. 1B). RNAseq
revealed that Brg1 regulated a total of 545 genes in CPs and 125
genes in CMs (P<0.05, ±1.5-fold). Reduced importance of Brg1 at
the CM stage is consistent with its reduced expression (Fig. 1C and
Fig. S1A). In CPs, Brg1 repressed 197 (36.1%) and activated 348
(63.9%) genes (Fig. 1C and Table S4). BRG1-activated genes were
enriched for sarcomere organization and assembly, and are essential
components of cardiac cell fate establishment (Fig. 1D). Of note,
Brg1 is essential for the activation of these lineage-specific genes, in
anticipation of the final differentiation status of the cells, but not
for their maintenance. Thus, Brg1 primes the cell type-specific
differentiation of CPs. In CMs, although BRG1 activated and
repressed roughly equal number of genes, it did not significantly
enrich for any biological processes, consistent with in vivo data
(Hang et al., 2010).
BRG1 binding correlates with sites of cardiac transcription
factor binding
To understand where BRG1 binds in the genome during cardiac
differentiation, we performed ChIPseq using a native antibody
against BRG1. In CPs, we found 4791 significant BRG1-binding
regions (Fig. 1E and Fig. S1B) and could detect weaker BRG1
occupancy in CMs (Fig. S1C), presumably owing to the low levels
of protein at this stage (Fig. 2A,E). In CPs, BRG1was bound to both
transcriptional start sites (TSS) and H3K27ac marked active
enhancer regions (Wamstad et al., 2012) (Fig. 1F and Fig. S1D)
and associated with 5274 genes (the two nearest genes flanking a
BRG1-binding site within 1 Mb). 21.9% of BRG1-activated and
20.9% of the BRG1-repressed genes overlapped with genes nearest
to a BRG1-binding site. Putative BRG1-activated targets were
enriched for cardiac muscle development, contraction and
circulatory system processes, whereas putative BRG1-repressed
targets were enriched for embryonic limb and skeletal system
development (Fig. S1E). Similar enrichment of biological processes
was observed for the two nearest genes flanking the BRG1-binding
sites within 100 kb (Fig. 1G and Fig. S1F). These results show
that BRG1 facilitates cardiac gene expression programs while
preventing other developmental programs.
Motif enrichment analysis using HOMER (Heinz et al., 2010)
revealed GATA motifs near BRG1-activated sites and T-box motifs
near BRG1 repressed sites, among others (Fig. 1H). Consistently,
BRG1-binding sites correlated well with GATA4- and TBX5-
binding sites in CPs (Fig. 1I) (Luna-Zurita et al., 2016), suggesting
that BRG1 interacts with cardiac TFs to regulate gene expression
during cardiac lineage commitment, as predicted from gain-of-
function experiments (Lickert et al., 2004; Takeuchi and Bruneau,
2009). Thus, BRG1 (and BRG1 containing complexes), likely in
collaboration with cardiac transcription factors, direct the cardiac
gene expression program while preventing expression of non-
cardiac genes.
The BRG1 complex shows dynamic composition during CM
differentiation
To understand the composition of BRG1-associated complexes
during cardiac differentiation, we immunopurified BRG1 using a
mouse embryonic stem (ES) cell line in which a 3×FLAG epitope
tag was added to the endogenous BRG1 open reading
frame (Attanasio et al., 2014), under moderately stringent binding
and wash conditions (300 mM NaCl, 0.02% NP40), and
competitively eluted BRG1-containing complexes in presence of
0.1 mg/ml 3×FLAG peptide. We isolated BRG1 complexes from
five different stages of cardiac differentiation: ES cells (ESCs),
embryoid bodies (EBs), cardiac mesoderm (MES), cardiac
progenitor (CP) and cardiac myocytes (CM) in biological
triplicates (Fig. 2A). An untagged control cell line similarly
processed in biological triplicates at each stage served as a
negative control. BRG1 complexes isolated from each of these
stages showed protein profiles similar to previously reported
complexes, and we have annotated the bands based on these
well-described complex migration patterns, keeping in mind that
each band was not excised and identified (Fig. 2A) (Ho et al.,
2009b). We performed mass spectrometry (MS) in biological
triplicates and technical duplicates, and compared peptide
intensities after normalizing against an untagged control, the bait
BRG1 protein, and across stages of differentiation, and identified
the composition of the BRG1 complexes at these five stages of
cardiac differentiation (Fig. 2B, Tables S1-S3). This resulted in
highly statistically significant identification of BAF complex
subunits. ESC-derived BRG1 complexes were enriched for
BRD9, GLTSCR1l (BICRAL), BCL7b, BCL7c, BAF45b
(DPF1), BAF155 (SMARCC1) and BAF60a (SMARCD1),
consistent with previous reports (Ho et al., 2009b; Kadoch and
Crabtree, 2013). We identified proteins enriched at mesoderm
(PDE4D, CRABP2, ARID1B), CP [BAF60b (SMARCD2),
POLYBROMO-1 (PRBM1), ARID2, BAF47 (SMARCB1),
BCL7a, BRD7 and BAF45a) and CM stages [BAF170
(SMARCC2), BAF60c (SMARCD3), BAF57 (SMARCE1),
SS18l1, BAF45c (DPF3), WDR5 and CC2D1B]. New BRG1-
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Fig. 1. BRG1 directs cardiac gene expression. (A) Schematics of cardiac differentiation. 4-hydroxyl tamoxifen (4OHT) was added at D4 and D8 to conditionally
delete Brg1 at CP and CM, respectively. Genotyping PCR shows a loxP site containing a 350 bp band and a faster migrating 313 bp band after addition of 4-OHT.
(B) Immunofluorescence of cTnT at day 10 of differentiation. (C) RNAseq of BRG1-regulated genes at CP and CM stages. (D) Gene ontology (GO)
biological processes enriched in BRG1 activated and repressed genes in CPs. (E) Input and BRG1 ChIPseq browser tracks in CPs. (F) Classification of BRG1
ChIPseq peaks into different genomic regions. Promoters are defined as being within 1 kb of the transcription start site. (G) BRG1-activated or -repressed genes
overlapping with the two nearest genes flanking the BRG1-binding sites shown in a Venn diagram. (H) Motifs enriched in BRG1-binding sites associated with
BRG1-activated and -repressed genes. (I) GATA4 and TBX5 binding correlates well over BRG1-binding sites in CPs.
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Fig. 2. BRG1-containing complexes dynamically change subunit composition during cardiac differentiation. (A) Schematic representation of cardiac
differentiation and isolation of BRG1 complexes by anti-FLAG immunopurification. SDS-PAGE showing BRG1 complexes from an untagged (lane 1) and a
Brg1-3x FLAG tagged mESC line differentiated to CMs at different stages (lanes 2-6). The BRG1 complex isolated at the CM stage (lane 6) is shown with
increased contrast in lane 7. Protein complexes were analyzed using 10% SDS-PAGE and stained with SyproRuby protein gel stain. Protein labels are based
on molecular mass and the nomenclature of BRG1-associated factors (BAFxx, where xx is molecular mass). These bands were not individually excised and
identified. (B) Mass spectrometric analysis of BRG1 complexes. The peptide intensities are normalized tomock untagged intensities and to BRG1 intensities, and
are further normalized across the row. Blue and red indicate depletion and enrichment, respectively; yellow indicates unchanged. Nuclear extracts of ESCs
(C) or CMs (D) resolved in a 10-30% glycerol gradient and BRG1-associated subunits detected by western blot. (E) Nuclear extracts resolved in 10% SDS-PAGE
from different stages of cardiac differentiation detected BAF/PBAF subunits by western blot. (F) A RNAseq expression profile (RPKM) of BAF/PBAF subunits
during cardiac differentiation. (G) Peptide intensities of immunopurified BAF170-3×FLAG protein after immunopurification-mass spectrometry, normalized to
mock and to BAF170 proteins, and across stages of differentiation. Blue and red indicate depletion and enrichment, respectively; yellow indicates unchanged.
4
STEM CELLS AND REGENERATION Development (2019) 146, dev174086. doi:10.1242/dev.174086
D
E
V
E
LO
P
M
E
N
T
•
A
cc
ep
te
d
m
an
u
sc
ri
p
t
interacting factors were identified, including CRABP2, KPNA2,
PDE4D, CSE1L, CC2D1B and, intriguingly,WDR5.WDR5 is well
known to be part of the MLL complex, and has been implicated in
human CHD (Zaidi et al., 2013). Glycerol gradient experiments
showed co-sedimentation of BAF/PBAF subunits in ES cells and
CMs, including WDR5 (Fig. 2C,D). Notably, we did not identify
cardiac transcription factors that we previously suggested associate
with BAF complexes (Lickert et al., 2004; Takeuchi and Bruneau,
2009; Takeuchi et al., 2011), likely owing to transient and weak
interactions with the complex. Functional assessment of BRG1
complexes by in vitro nucleosome repositioning or ATPase activity
assays indicated that stage-specific complexes had similar activities
(Fig. S2A-C). Thus, BRG1 complexes have dynamic subunit
composition that gradually changes during cardiac differentiation
and is enriched for specific subunits in cardiac lineages.
These results suggest that the BRG1 complex changes its
composition during cardiac differentiation and BAF subunits switch
from one isoform to other (e.g. BAF60a in ES is replaced by
BAF60c in CP/CM BAF complexes) or to a different protein
(BAF155 in ES cells to BAF170 in cardiac cells). The switch from
BAF155 in ES BAF to more abundant BAF170 in CP/CM, and
the appearance of BAF60c only in cardiac cell lineages during
differentiation were consistent with their expression pattern
(Fig. 2E). However, most subunits were not transcriptionally
regulated, and thus the assembly reflects developmental stage-
specific inclusion of these subunits (Fig. 2F).
To understand further the composition of cardiac-enriched
complexes, we immunopurified BAF170 using a mouse ESC line
in which a 3×FLAG epitope tag was added to the endogenous
BAF170 open reading frame at five different stages of cardiac
differentiation in biological triplicates. A non-FLAG-tagged line
processed similarly at each stage served as a negative control. We
eluted protein with FLAG peptides and analyzed FLAG purified
material by mass spectrometry. Many of the BRG1-associated
proteins at the CP and CM stages using BRG1 as bait were
also enriched using BAF170 as bait, with certain exceptions
(Fig. 2G). For example, ARID1b is enriched in the BRG1
immunopurification-MS at the MES-CM stages, whereas in the
BAF170 immunopurification-MS it is depleted. WDR5 was also
present in the complexes isolated by BAF170-immunopurification,
supporting its association with BAF complexes. In addition, we
detected the alternate ATPase BRM in the BAF170-FLAG
purification, indicating that BAF170 functions within separate
BRG1 and BRM complexes. These results suggest that dynamic
subunit composition and subunit switch are important aspects of
BAF complexes during cardiac differentiation.
BAF170 and BAF60c facilitate CM differentiation
Having established the dynamic composition of BAF complexes in
cardiac differentiation, we selected two subunits for functional
studies: BAF60c and BAF170. BAF60c is known to be important
for cardiac differentiation and morphogenesis in vivo, although little
is known about BAF170 in this context. We investigated the
functional roles of Baf60c and Baf170 by deleting them in ES cells
using TALEN or CRISPR strategies (Fig. 3A). Both Baf60cKO and
Baf170 KO cells underwent cardiac differentiation as observed by
beating cardiac myocytes and immunostaining of cardiac Troponin
T (Fig. 3B). However, cells lacking BAF170 had a delay in the onset
of beating (Fig. 3C) and both Baf60c and Baf170KO cells displayed
significant aberrations in beating, including number of beats
per minute and amplitude of beating (peak heights) (Fig. 3D),
which are indicative of abnormal cardiac differentiation. Directed
differentiation phenotypes must, of course, be interpreted with
caution, as a defective gene regulation programmay be overcome by
a strong set of instructive signals, resulting in a superficially
perceived mild or absent phenotype. For example, cells lacking both
the cardiac transcription factors NKX2-5 and TBX5 undergo
cardiac differentiation but with alterations in gene expression (Luna-
Zurita et al., 2016). Mice lacking BAF60c have impaired cardiac
morphogenesis, clearly indicating a crucial role for this subunit, but
do have CMs, consistent with our in vitro observations (Sun et al.,
2018). Nonetheless, to understand how these subunits regulate gene
expression, we collected cells at CP and CM stages, and carried
out RNAseq. In Baf60c KO CPs, a total of 474 genes (P<0.05, ±
1.5-fold) were deregulated, of which 45% were activated and 55%
were repressed, while a total of 382 genes are deregulated in Baf170
KO CPs, of which roughly equal number of genes were up- or
downregulated (Fig. S3A, Tables S5 and S6). Gene ontology
analyses revealed that Brg1- and Baf60c-dependent genes share
common functions in activating genes involved in cardiac and
muscle tissue development and contraction, while repressing
skeletal system and limb morphogenesis (Fig. S3C). Baf170-
dependent genes in CPs are involved in skeletal system
morphogenesis and pattern specification (Fig. S3C). However, in
both Baf60c and Baf170 KO CMs, a large percentage of genes were
repressed. In Baf60c KO CMs, out of a total 2646 genes, 72% were
repressed and 28% were activated, while in Baf170 KO CMs, out of
574 genes, 63% and 37% were repressed and activated, respectively
(Fig. S3B). Baf60cKOCM repressed genes were mostly involved in
biological adhesion, developmental process and cell motility,
whereas Baf170 KO CM repressed genes are involved in cell
differentiation and cellular developmental processes (Fig. S3D).
These results indicate a largely repressive function of these cardiac-
enriched subunits in gene regulation.
Overall comparison of the gene expression changes in CPs and
CMs lacking BRG1, BAF60c or BAF170 show that all three have
shared functions in CP gene expression, but that in CPs and CMs,
BAF60c and BAF170 regulate a cohort of genes independently of
BRG1 (Fig. 3E-G). These results could be due to an accrued effect
of BAF60c or BAF170 loss in gene expression during cardiac
differentiation or divergent role of these two subunits from BRG1,
suggesting their association in a different BAF complex or potential
independent function outside of BAF complexes.
BAF subunits modulate temporal chromatin accessibility
and facilitate cardiac gene expression programs
To understand the function of BRG1, BAF60c and BAF170 in gene
expression regulation, we used ATACseq (Corces et al., 2017) to
examine chromatin accessibility genome wide in CPs and CMs. We
compared differential chromatin accessibility profiles in Brg1
conditional KOs, and Baf60c and Baf170 KOs in CP and CM
cells, and analyzed the two nearest (within 100 kb) genes to an
ATACseq site, for enrichment of biological processes (Fig. 4).
In CPs, Brg1maintains chromatin accessibility near genes involved
in cardiovascular development, cardiac tissue morphogenesis and
regulation of cell differentiation (Fig. 4A, clusters a, g and i),
and prevents chromatin accessibility near genes involved in
transcriptional regulation and chromatin organization (Fig. 4A,
cluster e). In the absence of BAF60c, accessibility was increased at
genes that are involved in non-cardiac cell differentiation and
regulation of cell migration (Fig. 4A, cluster f ). In contrast, in the
absence of either BAF60c or BAF170, accessibility was reduced
near genes involved in cardiovascular development (Gata4, Tbx5,
Myocd and Myh7), calcium handing (Ryr2) and muscle contraction
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Fig. 3. BAF60c and BAF170 regulate both common and distinct gene expression programs compared with BRG1. (A) Loss of BAF60c and BAF170
proteins in respective KO cells detected by western bot in CPs. BRG1 levels are shown as loading controls. (B) Immunofluorescence of cardiac troponin T protein
in wild-type, BAF60cKO and BAF170 KO cells in CMs. (C) Schematics showing the onset of beating in differentiating CMs (an average of multiple wells and
differentiations). (D) Assessments of beating properties of wild-type, BAF60c KO and BAF170 KO CMs obtained by measuring the number of beats per
minute and amplitude of beating represented by peak heights. Boxplots show data from the 1st quartile to the 3rd quartile with horizontal lines indicating the
median. Whiskers are 1.5 times the interquartile range, with outliers shown outside of the whiskers. (E) Venn diagram shows an overlap of significantly affected
genes (±1.5-fold, P<0.05) in the absence ofBrg1, Baf60c and Baf170 at CP and CM stages. (F,G) Heat maps comparing genes significantly deregulated in any of
the three genotypes over their respective wild-type counterpart at CP (F) and CM (G) stages. Clusters are shown in vertical colored bars on the left and
representative genes involved in various biological processes are shown on the right of the heat map.
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(Scn5a, Scn10a and Kcnq1) (Fig. 4A, clusters c and d; Fig. 4B,C).
Loss of BAF60c and BAF170 increased chromatin accessibility
near genes involved with embryonic limb and skeletal muscle
development (Myf5,Myf6 and Tbx2) and early embryo development
(Cer1, Dkk1, Fgf9 and Gsc) (Fig. 4A, cluster h-j and Fig. 4D).
In CMs, loss of BRG1 did not change chromatin structure,
consistent with gene expression (Figs 4E and 1C), whereas loss of
BAF60c and BAF170 increased chromatin accessibility near
genes involved in chromatin and transcription regulation (Ino80d
and Kat7), and hematopoietic differentiation (Gata2). BAF60c
Fig. 4. BRG1, BAF60c and BAF170 regulate temporal chromatin accessibility. (A,E) Heat maps of significantly affected ATAC-seq peaks (FDR <0.05,
twofold change) in BRG1 conditional, BAF60c KO and BAF170 KO over their respective wild-type counterparts in CPs (A) or CMs (E). Enriched biological
processes of the two nearest genes (within 100 kb) to the ATACseq peaks were analyzed using GREAT (McLean et al., 2010) and are shown to the right with
representative genes. (C,H) Browser tracks showing delayed opening of Tnnt2 promoter chromatin (H) and loss of Scn10a enhancer in absence of BAF170 (C).
(B,D,F,G) Chromatin opening and closing near Tbx5 (B) and Myf5 (D) in the absence of BAF60c and BAF170 in CPs, and chromatin closing in Tpm1 (F) and
Mef2c (G) in the absence of BAF60c in CMs are shown.
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alone is implicated in promoting chromatin accessibility near CP
genes (Gata4, Tbx5 andHand2), whereas BAF60c and BAF170 are
important in chromatin accessibility near genes involved in cardiac
function (Myom1, Tpm1,Myh6 andMyl3) (Fig. 4F) and calcium ion
transport (Cacna1c and Cacna2d4). Uniquely, they also regulate
chromatin near signaling and cell migration genes (Fig. 4G).
Furthermore, in the absence of BAF170, we observed delayed
accessibility of the Tnnt2 promoter (Fig. 4H), consistent with
delayed onset of beating (Fig. 3C), and impaired accessibility at an
enhancer in the Scn10a gene (Fig. 4C). This Scn10a region is a
known TBX5-dependent enhancer of Scn5a, and was identified as
containing a GWAS SNP associated with altered electrophysiology
in humans (van den Boogaard et al., 2014, 2012). These data
provide evidence of the unique and shared functions that
individual BAF subunits exert in order to regulate chromatin
structure.
Both BAF170 and BAF60c regulate BAF complex
composition
BAF60c and BAF170 have crucial roles in regulation of chromatin
structure and transcription. It is not clear whether mammalian BAF
complex composition is reliant on the presence of specific subunits.
Importantly, BAF60 and BAF170 family subunits are part of the
initiating steps in BAF complex assembly (Mashtalir et al., 2018).
To understand the nature of BAF complexes formed in the absence
of these cardiac-enriched subunits, we immunopurified BRG1-
3×FLAG complexes from ESC lines lacking BAF60c or BAF170 at
CP and CM stages. SDS-PAGE revealed increased abundance of
BRG1-containing complexes in BAF170 KO CMs (Fig. 5A).
During the CP to CM transition, BRG1 complex abundance is
normally reduced in wild-type cells (Fig. 2A, compare lane 5 with
lane 6) and in BAF60c KO cells (Fig. 5A, compare lanes 2-4 with
lanes 5 and 7). In BAF170 KO the abundance of BAF complexes
remained unchanged (Fig. 5A, compare lanes 8 and 9 with lanes 10
and 11), indicating a crucial role for BAF170 in BRG1 complex
abundance.
MS analyses of these complexes revealed significant differences
in subunit composition in the absence of BAF60c or BAF170
(Fig. 5B,C). In CPs, BRG1 complexes lacking BAF60c had reduced
association of BAF53a, BRD7, BAF45a and BAF45c, and were
enriched for BAF45d, BAF47, SS18, BAF155 and BAF60a
(Fig. 5B and Fig. S4A). In CMs, we observed increased
association of many subunits with BRG1 in the absence of
BAF60c (Fig. 5B, Fig. S4A and S4B). Similarly, BAF170 loss
led to BRG1-containing complexes with reduced association of
BCL7a, BAF45d, BAF60c, BAF47 and BAF53a (ACTL6A), and
increased association of BAF45c, SS18L1 (CREST) and BAF180
(PRBM1) with BRG1 in CPs. In CMs, loss of BAF170 reduced
association with BAF60c and increased association with BAF155
and BAF60b (Fig. 5C, Fig. S4A and S4B). The altered complexes
formed are not due to changes in the transcriptional level of BAF
subunits (Fig. S4C).
These results suggest that a fine balance exists in the composition
of the BAF complex and perturbation of one subunit extends to the
association of other subunits in the complex. It further indicates
that different subunits or isoforms substitute for the absence of one
or more subunits. For example, both BAF60a and BAF60b
substitute for the lack of BAF60c, and depletion of BAF45c is
balanced by enrichment of BAF45a (Fig. S4B). These results
emphasize that subunit switching and substitution in BAF complex
composition could be an important mechanism in cardiac lineage
specification.
BAF170 facilitates temporal BRG1 dissociation from
the genome
We explored the possibility that BAF60c or BAF170 help direct the
genomic localization of BRG1. In CPs, BRG1 binds to a set of 4791
sites (Fig. S1B) and these are largely unaffected in absence of
BAF170 (Fig. 5D). BRG1 binding at these site is severely reduced
in CMs, perhaps owing to the reduced abundance of BRG1-
containing complexes (Fig. 2A, compare lane 5 with 6; Fig. 2E,
BRG1 western, compare CP with CM). However, in the absence
of BAF170, BRG1 binding at a large subset of these sites is retained
in CMs (Fig. 5D), consistent with the increased relative abundance
of BRG1-containing complexes. These chromatin regions are
accessible in CPs and are normally subsequently inaccessible in
CMs, but remain accessible in absence of BAF170, consistent with
retained BRG1 complexes remodeling these regions (Fig. 5E).
In CMs, BRG1 weakly bound to 3473 sites, and lack of BAF170
increased BRG1 binding to some of these (Fig. 5F), whereas the
absence of BAF60c reduced the binding of BRG1. These binding
dynamics correlated with chromatin accessibility (Fig. 5G). This
suggests that recruitment of BRG1-inclusive complexes is regulated
by cardiac-specific subunits, and that concomitant dynamic
expulsion of the complex is also highly regulated by similar
processes.
DISCUSSION
BRG1-containing complexes respond to and modulate lineage
decisions and differentiation in cardiac development by
incorporating specific subunits at discrete stages. These specialized
BAF complexes regulate distinct gene expression programs to drive
cardiogenesis while simultaneously repressing alternate non-cardiac
developmental programs. Our results suggest that BAF complexes
use multiple interdependent mechanisms, including switching
subunits or isoforms, regulating relative subunit abundance,
altering BRG1 recruitment and expulsion strategies, to modulate
dynamics of cardiac differentiation. This unanticipated complexity
of chromatin complex regulation emerges as a crucial determinant of
differentiation.
Subunit composition switching of chromatin remodeling
complexes have been reported during neural development
(Lessard et al., 2007; Nitarska et al., 2016; Yoo et al., 2009) and
skeletal myogenesis (Goljanek-Whysall et al., 2014; Saccone et al.,
2014). For example, during myogenic differentiation, BAF60c
expression is facilitated over the alternative isoforms BAF60a and
BAF60b, which are post-transcriptionally repressed by myogenic
microRNAs. However, the systematic immunopurification-
MS-based discovery of BAF/PBAF complex subunits during the
time course of a well-regulated differentiation process has, to date,
not been achieved. Importantly, we show that BRG1-associated
subunits at different stages of cardiac differentiation form specific
complexes to activate or repress specific transcriptional programs.
In addition, we determine that the presence of specific BAF subunits
greatly dictates the overall composition, and therefore function, of
the complex.
The continued roles played by BAF60c and BAF170 are
intriguing considering the reduced role of BRG1 in later stages of
cardiac differentiation. The incorporation of these subunits within a
BRM-containing complex could explain this, although the apparent
absence of a developmental or postnatal cardiac phenotype in BRM-
null mice might indicate minimal importance of these complexes
(Reyes et al., 1998). It has been suggested that BAF60c may
function independently of the BAF complex (Forcales et al., 2012;
Wang et al., 2013), although there is no evidence for this in cardiac
8
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Fig. 5. Cardiac-enriched BAF subunits regulate BRG1 complex relative abundance and genome binding. (A) An immunoprecipitated and FLAG-eluted
BRG1-containing complex isolated from untagged cells or from cells lacking BAF60c or BAF170 in CPs and CMs analyzed using 10% SDS-PAGE.
(B,C) Peptide intensities of FLAG immunopurification-mass spectrometry in the absence of BAF60c (B) or BAF170 (C) in CPs and CMs after normalization to
mock control and to BRG1 levels, and across stages of differentiation. (D) ChIP-Seq showing BRG1 binding over 4791 peaks in wild-type and BAF170 KO CPs
(left panel). BRG1 binding over these same 4791 CP sites in wild-type, BAF170 KO or BAF60c KO CMs (right panel). (E) ATACseq signal over 4791
BRG1-binding sites in CPs and CMs for the indicated genotypes. (F) BRG1 ChIP over 3473 peaks in wild-type, BAF170 KO and BAF60c KO CMs. (G) ATACseq
signal over 3473 CM BRG1-binding sites over the indicated genotypes in CMs.
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cells. It is also possible that the altered BAF complex assembly in
the absence of BAF60c or BAF170 creates a set of complexes with
anomalous function, thus leading to aberrant gene expression.
BAF60c and BAF170 are essential for BRG1 complex
composition. Altered association or dissociation of several
subunits in the absence of BAF60c or BAF170 indicates the
presence of sub-modules within the BAF complex mediated by
these subunits. Our observations are consistent with reports in yeast
SWI/SNF complexes where the absence of specific subunits forms
sub-modules or altered SWI/SNF complex composition (Dutta
et al., 2017; Sen et al., 2017; Yang et al., 2007). Thus, phenotypic
observations in absence of a particular subunit may be the result of
disruption of a module containing many subunits. Conflicting
evidence regarding this mechanism has been shown for other BAF
complex subunits in mammalian cells (Nakayama et al., 2017;
Wang et al., 2017). We interpret our results as indicating that a stable
complex with broadly altered composition exists in the absence of
BAF60c or BAF170.
BRG1 binding to genomic sites in CPs and putative BRG1 targets
both have crucial roles in the promotion of cardiac gene expression
programs, while repressing non-cardiac fate. BRG1 binding is
greatly reduced in CMs, indicating diminished BRG1 function. Our
finding that BAF170 promotes BRG1 dissociation from the genome
indicates a potential mechanism of BAF170-mediated gene
regulation during differentiation. How BAF170 regulates genomic
expulsion of BRG1 is currently not understood, but association of
BAF170 with BRM-containing complexes in CM might evict
BRG1 from BAF complexes as both BRG1 and BRM are mutually
exclusive. Furthermore, a concomitant increase in BAF170 and
decrease in BAF155 association with BRG1-containing complexes
during cardiac differentiation might make BRG1 prone to post-
transcriptional modification and proteasome-mediated degradation,
as BAF155 is known to stabilize BRG1-containing complexes
(Sohn et al., 2007). Consistently, we observe increase in BRG1
complex abundance in the absence of BAF170 in CMs.
In conclusion, our study identifies morphing combinations of
specific BAF subunits that form and change subunit compositions
during cardiac differentiation, and drive stage-specific cardiac gene
expression programs. These results are consistent with the known
in vivo roles of BAF complex subunits (Hang et al., 2010; Sun et al.,
2018; Takeuchi et al., 2011). Genetic dissection of individual
subunit contribution clearly unveils a profound and specific
function of individual BAF complex subunits. How BAF
chromatin remodelers with different subunit composition provide
specificity to gene expression programs will be the focus of future
studies.
MATERIALS AND METHODS
Cardiomyocyte differentiation
Mouse embryonic stem cells (ESCs) were cultured in feeder-free condition
sin serum and leukemia inhibitory factor-containing medium. CMs were
differentiation as described previously (Kattman et al., 2011; Wamstad
et al., 2012). Brg1 was deleted in presence of 200 nM 4-hydroxytamoxifen
for 48 h with control cells treated similarly with tetrahydrofuran (Ho et al.,
2009a).
Knockout cell line generation
BAF60c was inactivated by targeting exon 2 of Baf60c with two pairs of
TALENs following the methods of Sanjana et al. (2012), except a CAGGS
promoter replaced the CMV promoter (Giorgetti et al., 2014). The targets of
TALEN are as follows: GCCCCCTAAGCCCTCTCCAGAGAACATCC-
AAGCTA GAATGACTTGGTCGCTGCTAC and CCCGCCCCTCTCC-
AAGACCCTGGGTTGGTA ACCCTGCGCTGAGCGATGAGTGGGAG.
BAF170 was targeted using CRISPR/Cas9 with sgRNA targeting
exon 2 of Baf170 following the protocol described by Cong et al. (2013).
sgRNA were cloned to a BbsI-digested pX330 vector by annealing
the following primers: 5′ caccg CGCACCGCTTACTAAACTGC 3′ and
5′ aaac GCAGTTTAGTAAGCGGTGCG c 3′ (lowercase indicates the BbsI
digestion site). Targeting vector was constructed by cloning 458 and 459 bp
of Baf170 DNA upstream and downstream of midpoint of sgRNA target site
into KpnI-XhoI and BamH1-NotI sites of pFPF (a derivative of Addgene
plasmid #22678 in which neomycin is replaced with puromycin cassette).
2.5 μg of each TALENBaf60c plasmid or the sgRNA plasmid, plus 20 μg of
BAF170 targeting constructs were used for transfection. Single clones were
selected, grown, PCR genotyped and DNA sequenced.
Nuclear extract preparation, western blot and anti-FLAG
immunoaffinity purification
Nuclear extracts were prepared using protocols described previously
(Abmayr et al., 2006). Western blotting was performed using standard
techniques with PVDF membranes. Primary antibodies used were anti-
BRG1 (Abcam, ab110641, 1:1000), anti-FLAG (Sigma, F1804, 1:1000),
anti-BAF155 (Bethyl, A301-021A, 1:1000), anti-BAF170 (Bethyl, 1:1000,
A301-39A), anti-BAF60c (Cell Signaling Technology, 62265, 1:1000) and
anti-WDR5 (Bethyl, A302-430A, 1:2000 dilution). Secondary antibodies
used were donkey anti-rabbit IRDye 800cw (Licor, 926-32213, 1:10,000),
donkey anti-mouse IRDye 800cw (Licor, 925-32212, 1:10,000) and donkey
anti-goat IRDye 680cw (Licor, 925-68074-1:10,000).
For immunoaffinity purification of BAF complexes, we leached out
nuclear protein by using high-salt and glycerol, and did not digest DNA or
RNA. Cell pellets (108 cells) were incubated in a hypotonic buffer (10 mM
TrisCl, 10 mM NaCl) and centrifuged at 500 g to separate the cytoplasmic
fraction from nuclei. Nuclear proteins were leached out in nuclear extract
buffer containing 0.3 M NaCl, 0.02% NP40 and 20% glycerol by rotating
for 1 h at 4°C in absence of DNase or RNase. Soluble nuclear extracts were
separated by centrifuging at 100,000 g for 1 h. The nuclear extract was
incubated with 50 μl of anti-FLAG M2 agarose gel (Sigma, A2220)
overnight, washed 10 times with the same nuclear buffer containing 0.3 M
NaCl, 0.02% NP40 and 20% glycerol, and batch eluted with 0.1 mg/ml
FLAG peptides (ELIM Biopharmaceutical). Protein complexes were
resolved using 10% SDS PAGE.
Mass spectrometry
Protein complexes were digested with trypsin for LC-MS/MS analysis.
Samples were denatured and reduced in 2 M urea, 10 mMNH4HCO3, 2 mM
DTT for 30 min at 60°C, then alkylated with 2 mM iodoacetamide for
45 min at room temperature. Trypsin (Promega) was added at a 1:100
enzyme:substrate ratio and digested overnight at 37°C. Following digestion,
samples were concentrated using C18 ZipTips (Millipore) according to the
manufacturer’s specifications. Desalted samples were evaporated to dryness
and resuspended in 0.1% formic acid for mass spectrometry analysis.
Digested peptide mixtures were analyzed by LC-MS/MS on a Thermo
Fisher Scientific LTQ Orbitrap Elite mass spectrometry system equipped
with a Proxeon Easy nLC 1000 ultra high-pressure liquid chromatography
and autosampler system. Samples were injected onto a C18 column
(25 cm×75 μm I.D. packed with ReproSil Pur C18 AQ 1.9 µm particles) in
0.1% formic acid and then separated with a 1 h gradient from 5% to 30%
ACN in 0.1% formic acid at a flow rate of 300 nl/min. The mass
spectrometer collected data in a data-dependent fashion, collecting one full
scan in the Orbitrap at 120,000 resolution followed by 20 collision-induced
dissociation MS/MS scans in the dual linear ion trap for the 20 most intense
peaks from the full scan. Dynamic exclusion was enabled for 30 s with a
repeat count of 1. Charge state screening was employed to reject analysis of
singly charged species or species for which a charge could not be assigned.
Rawmass spectrometry data were analyzed using the MaxQuant software
package (version 1.3.0.5) (Cox and Mann, 2008). Data were matched to the
SwissProt mouse protein sequences (downloaded from UniProt on 19 July
2016). MaxQuant was configured to generate and search against a reverse
sequence database for false discovery rate (FDR) calculations. Variable
modifications were allowed for methionine oxidation and protein
N-terminus acetylation. A fixed modification was indicated for cysteine
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carbamidomethylation. Full trypsin specificity was required. The first search
was performed with a mass accuracy of ±20 ppm and the main search was
performed with a mass accuracy of ±6 ppm. A maximum of five
modifications were allowed per peptide. A maximum of two missed
cleavages were allowed. The maximum charge allowed was 7+. Individual
peptide mass tolerances were allowed. For MS/MS matching, a mass
tolerance of 0.5 Da was allowed and the top six peaks per 100 Da were
analyzed. MS/MS matching was allowed for higher charge states, water and
ammonia loss events. The data were filtered to obtain a peptide, protein and
site-level FDRof 0.01. The minimum peptide length was seven amino acids.
Results were matched between runs with a time window of 2 min for
technical duplicates. All precursor (MS1) intensities of valid peptide
matches were quantified by the Maxquant LFQ algorithm using the match
between runs option to minimize missing values.
For statistical analysis, the quantitative change of peptides that were
uniquely assigned to protein isoforms across all immunopurifications were
compared with the MSstats R package (v. 2.3.4) (Choi et al., 2014). Briefly,
all peak intensities were Log2-transformed and their distributions were
median centered across all runs using the scale option. All remaining
missing intensity values were imputed by setting their value to minimal
intensity value per run, as an estimate for the MS Limit Of Quantitation. The
normalized dataset was then analyzed by fitting a mixed effects model per
protein using the model without interaction terms, unequal feature variance,
and restricted scope of technical and biological replication. The average
change (Log2-Fold-Change) of the model-based abundance estimate was
computed by comparing replicates of each differentiation stage against
the ESC undifferentiated pool. Proteins with a greater than fourfold
change (Log2 Fold Change >2) and test P-value<0.05 were determined
as significantly altered during differentiation. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE (Perez-Riverol et al., 2018) partner repository with the
dataset identifier PXD012721.
Nucleosome reconstitution, repositioning and ATPase assay
Recombinant Xenopus laevis histone octamers were reconstituted on a
601-nucleosome positioning DNA (Lowary andWidom, 1998) as described
previously (Hota et al., 2013). Nucleosome repositioning and ATP
hydrolysis assays were performed as described previously (Hota et al.,
2013).
RNA-sequencing
Total RNA was isolated from biologically triplicate samples using
miRNeasy micro kit with on-column DNase I digestion (Qiagen). RNA-
seq libraries were prepared using the Ovation RNA-seq system v2 kit
(NuGEN). Libraries from the SPIA amplified cDNA were made using the
Ultralow DR library kit (NuGEN). RNA-seq libraries were analyzed using
Bioanalyzer, quantified using KAPA QPCR and paired-end 100 bp reads
were sequenced using a HiSeq 2500 instrument (Illumina). RNA reads were
aligned with TopHat2 (Kim et al., 2013), counts per gene calculated using
feature Counts (Liao et al., 2014) and edgeR (Robinson et al., 2010) was
used for the analysis of differential expression. K-means clustering and
pheatmap functions in R were used to cluster and generate heatmaps. GO
enrichment analysis were performed using GO_Elite (Zambon et al., 2012).
ChIP-Seq
Chromatin immunoprecipitations were performed according to O’Geen et al.
(2011). Briefly, cells were double crosslinked with 2 mM disuccinimidyl
glutarate (DSG) and 1% formaldehyde, and quenched with 0.125 M glycine.
Frozen pellets (5×107) were thawed, washed, dounced and digested with
MNase. Chromatin was sonicated at output 4 for 30 s twicewith a 1min pause
between cycles then centrifuged at 10,000 g for 10 min at 4°C and stored at
−80°C. Chromatin (40 μg) was diluted to fivefold, pre-cleared for 2 h
followed by immunoprecipitation with anti-Brg1 antibody (Abcam, 110641)
for 12-16 h. 5%of samples were used as input DNA.Antibody-boundBRG1-
DNA complexes were immunoprecipitated using 25 μl of M-280 goat anti-
rabbit IgG dyna beads for 2 h, washed a total of ten times with buffers [twice
with IP wash buffer 1 containing 50mMTris.Cl (pH 7.4), 150mMNaCl, 1%
NP-40, 0.25% sodium deoxycholate and 1 mM EDTA), five times with IP
wash buffer 2 containing 100mMTris.Cl (pH 9.0), 500mMLiCl, 1%NP-40
and 1% sodium deoxcholate, and then twice with IP wash buffer 2 along with
150 mM NaCl] of increasing stringency and eluted with 200 μl of elution
buffer [10 mM TrisCl (pH 7.5), 1 mM EDTA and 1%SDS). Samples were
reverse crosslinked, digested with proteinase K and RNAse A, and purified
using AMPure XP beads (Beckman Coulter). To prepare libraries for
sequencing, DNA was end repaired, A-tailed, adapter ligated (Illumina
TrueSeq) and PCR amplified. PCR-amplified libraries were size selected and
ampure purified. The concentration and size of eluted libraries was measured
(Qubit and Bioanalyzer) before sequencing using a NEBNextSeq sequencer.
Reads (single end 75 bp) were trimmed using fastq-mcf and aligned to
mouse genome mm9 assembly using Bowtie (Langmead et al., 2009).
Minimum mapping quality score was set to 30. Statistically enriched bins
with a P-value threshold set to 1×106 were determined using input DNA as
the background model (Thomas et al., 2017). Galaxy (usegalaxy.org/) was
used to pool multiple replicates to generate browser tracks and tornado plots.
GREAT (McLean et al., 2010) was used to generate gene lists near BRG1
peaks. The bioconductor package ‘annotatr’ version 3.8 (Cavalcante and
Sartor, 2017) was used to classify BRG1-binding sites within promoters
(<1 kb from the transcription start site), introns, intergenic regions and
exons. The HOMER (Heinz et al., 2010) motif enrichment package was
used to enrich DNA motifs in BRG1-binding sites. HOMER calculates the
q-value of known motifs to statistically confirm to Benjamini-Hochberg
multiple hypothesis testing corrections.
ATAC sequencing
Assay for transposase-accessible chromatin using sequencing (ATAC-seq)
was performed according to Corces et al. (2017) in two to five biological
replicates. Briefly, 50,000 cells (>95% viability) were lysed, washed and
tagmented for 45 mins and 3 h for CP and CM cells, respectively. DNAwas
purified and amplified using universal Ad1 and barcoded reverse primers
(Corces et al., 2017). Libraries were purified, quantified and analyzed on a
bioanalyzer and sequenced on a NEB NextSeq 550 sequencer using
Illumina NextSeq 500/550 High Output v2 kit (150 cycles). Sequencing
image files were de-multiplexed and fastq generated. Reads (paired end
75 bp) were trimmed and aligned to mouse genome mm9 assembly using
Bowtie (Langmead et al., 2009) with a minimum mapping quality score of
30. Statistically enriched bins with a P-value threshold set to 1×106 were
determined (Thomas et al., 2017). UCSC genome browser and IGV were
used to view the browser tracks. Galaxy (usegalaxy.org) was used to pool
multiple replicates to generate browser tracks and tornado plots. GREAT
was used to generate gene lists near ATACseq sites.
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